| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5727166 | Journal of Vascular and Interventional Radiology | 2017 | 11 Pages |
Abstract
Aspirin and beta-blockers are associated with significantly improved survival when taken at the time of embolization for HCC. Aspirin was not associated with survival differences after locoregional therapy for NET or colorectal liver metastases, suggesting an HCC-specific effect.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
F. Edward MD, PhD, Etay MD, PhD, Hooman MD, Karen T. MD, Joseph P. MD, PhD, Constantinos T. MD, PhD, James J. MD, Stephen B. MD,